# Amphastar Pharmaceuticals, Inc. (NASDAQ: AMPH), Rancho Cucamonga, CA – FDA Inspections

Source: https://www.keypedia.com/companies/amphastar-pharmaceuticals-inc/e90eb882-5679-4c85-bbc8-f69ca69cc537

> Inspection records and compliance data for Amphastar Pharmaceuticals, Inc. in Rancho Cucamonga, California. 15 FDA inspections on record (1 OAI), 3 Form 483s, last inspected November 07, 2025. Publicly traded as NASDAQ: AMPH.

---

## Details

- Name: Amphastar Pharmaceuticals, Inc.
- FEI Number: 3002936358
- Business Operations: API/FDF ANALYTICAL TESTING, CLINICAL BIOEQUIVALENCE OR BIOAVAILABILITY STUDY, FDF MANUFACTURE, IN VITRO BIOEQUIVALENCE OR BIOANALYTICAL TESTING
- Address Line 1: 11570 6th St
- City: Rancho Cucamonga
- State: California
- Zip Code: 91730
- Country Name: United States
- Address: 11570 6th St, Rancho Cucamonga, California 91730, United States
- Country: United States

## Stock

- Stock ticker: AMPH
- Exchange: NASDAQ
- Share price: $28.87
- Market cap: $1.2B
- Price as of: November 13, 2026

## Related Documents

- [CRL - Amphastar Pharmaceuticals, Inc. - Unknown Date](https://www.keypedia.com/records/crl/amphastar-pharmaceuticals-inc/1acdb785-a6cd-4a73-acc7-230e9092fbf3) — source: FDA, date: Invalid Date
- [CRL - Amphastar Pharmaceuticals, Inc. - Unknown Date](https://www.keypedia.com/records/crl/amphastar-pharmaceuticals-inc/25af10c9-8faf-4ca2-9e1b-9aba59be2196) — source: FDA, date: Invalid Date
- [483 - Amphastar Pharmaceuticals, Inc. - 2025-11-07](https://www.keypedia.com/records/483/amphastar-pharmaceuticals-inc/9fca3bac-d02d-4ef5-b7cc-ab5e97be5cb7) — source: FDA, date: November 7, 2025
- [FDA Inspection 1290538 - Amphastar Pharmaceuticals, Inc. - 2025-11-07](https://www.keypedia.com/records/fda_inspections/amphastar-pharmaceuticals-inc/84de8825-ab9e-4fa3-a9c3-56d089df0daa) — source: FDA, date: November 7, 2025
- FDA Inspection 1266798 - Amphastar Pharmaceuticals, Inc. - 2025-04-03 — source: FDA, date: April 3, 2025
- [FDA Inspection 1266798 - Amphastar Pharmaceuticals, Inc. - 2025-04-03](https://www.keypedia.com/records/fda_inspections/amphastar-pharmaceuticals-inc/f3a88961-407c-4d84-af4c-f19faea69e77) — classification: No Action Indicated (NAI), source: FDA, date: April 3, 2025
- [483 - Amphastar Pharmaceuticals, Inc. - 2024-03-01](https://www.keypedia.com/records/483/amphastar-pharmaceuticals-inc/51a97c4a-18cd-4d34-8ca8-0451323cecd2) — source: FDA, date: March 1, 2024
- FDA Inspection 1229403 - Amphastar Pharmaceuticals, Inc. - 2024-03-01 — classification: Voluntary Action Indicated (VAI), source: FDA, date: March 1, 2024
- FDA Inspection 1144508 - Amphastar Pharmaceuticals, Inc. - 2021-06-22 — classification: No Action Indicated (NAI), source: FDA, date: June 22, 2021
- FDA Inspection 1113865 - Amphastar Pharmaceuticals, Inc. - 2019-11-22 — classification: No Action Indicated (NAI), source: FDA, date: November 22, 2019
- FDA Inspection 1115634 - Amphastar Pharmaceuticals, Inc. - 2019-11-21 — classification: No Action Indicated (NAI), source: FDA, date: November 21, 2019
- FDA Inspection 1100047 - Amphastar Pharmaceuticals, Inc. - 2019-07-25 — classification: No Action Indicated (NAI), source: FDA, date: July 25, 2019
- [FDA Inspection 1079028 - Amphastar Pharmaceuticals, Inc. - 2019-02-12](https://www.keypedia.com/records/fda_inspections/amphastar-pharmaceuticals-inc/b297f414-5cd0-46c7-a3cf-138b1f5293af) — classification: Voluntary Action Indicated (VAI), source: FDA, date: February 12, 2019
- FDA Inspection 1009137 - Amphastar Pharmaceuticals, Inc. - 2017-03-31 — classification: Voluntary Action Indicated (VAI), source: FDA, date: March 31, 2017

## Related Companies

- [Armstrong Pharmaceuticals, Inc.](https://www.keypedia.com/companies/armstrong-pharmaceuticals-inc/84c3c49a-e2b4-4f1b-bc4c-327fddf8066d)
- [Teva Womens Health, LLC](https://www.keypedia.com/companies/teva-womens-health-llc/eea6ef47-7964-4c7b-8094-2fd46b336b60)
- [Teva Puerto Rico LLC](https://www.keypedia.com/companies/teva-puerto-rico-llc/1ed3f946-be5e-473a-ae76-ac9abcde2d21)
- [Sun Pharmaceutical Industries, Inc.](https://www.keypedia.com/companies/sun-pharmaceutical-industries-inc/1a56d6cb-288c-42d5-9558-e4301ffebc65)
- [Padagis US LLC](https://www.keypedia.com/companies/padagis-us-llc/d356236a-0058-4d8b-86ad-56011f641c96)
- [King Pharmaceuticals LLC](https://www.keypedia.com/companies/king-pharmaceuticals-llc/d90c79dd-4325-4185-bf42-87c7f116f6c5)
- [Sunrise Pharmaceutical, Inc.](https://www.keypedia.com/companies/sunrise-pharmaceutical-inc/3e90c0a2-44c0-46f7-a6ff-ee1377824088)
- [Organon Pharma (UK) Ltd.](https://www.keypedia.com/companies/organon-pharma-uk-ltd/5fa8cf74-45d3-45f6-abb3-6918d01961a6)
- [Hikma Farmaceutica, (Portugal) S.A.](https://www.keypedia.com/companies/hikma-farmaceutica-portugal-sa/39ec9f09-5b00-4a12-aa9b-2add04e825e0)
- [Teh Seng Pharmaceutical Mfg. Co., Ltd. 3rd Plant](https://www.keypedia.com/companies/teh-seng-pharmaceutical-mfg-co-ltd-3rd-plant/410dc182-1791-459c-8b4b-afa1aa9fbc49)

## Related Officers

- [Gisela Sharp](https://www.keypedia.com/people/gisela-sharp/bff97a47-05ca-41a4-b9ce-477876596db5)
- [Homero W. Aguilar](https://www.keypedia.com/people/homero-w-aguilar/fbc95655-a1a8-456f-a09a-7bc8a213a786)
- [Chemist/Investigator - Pharmaceutical Quality](https://www.keypedia.com/people/walden-h-lee/18131eea-d1cb-47c4-af79-bea22d436031)
- [issuing_officer](https://www.keypedia.com/people/kara-a-scheibner/63643a3f-4a8e-4dcc-8f1a-6fcf98519aad)
- [Samson O. Oluseye](https://www.keypedia.com/people/samson-o-oluseye/bfe102f5-25cb-4ed9-9e69-2ec5ec0a047f)